Temozolomide and treatment of malignant glioma.

By H. Friedman, T. Kerby, H. Calvert. Clinical Cancer Research, 2000

757 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment (2017, background): “Although TMZ has slightly increased the survival of patients, it is also responsible for inducing many side effects (Friedman et al., 2000; Dario and Tomei, 2006; Singhal et al., 2007; Sengupta et al., 2012).”